487-26-3

应用筛选条件

关键词:'487-26-3'

显示 1-23 共 23 条结果关于 "487-26-3" 范围技术文档

, J. Biol. Chem., 265: 9188-9193 (1990). Comstock, K.E., et al., Arch. Biochem. Biophys., 311: 487-495 (1994). Note: This purified product exhibits LOW enzymatic activity for CDNB, the

Data Sheet - 70153

J. Clin. Microbiol. 26, 875 (1988); E. Leifson, Am. J. Hyg. 24, 423 (1936) 2. A. Klett, Zeitsch. für Hyg. und Infekt. 33, 137 (1900) 3. F. Guth, Zbl. Bakt. I. Orig. 77, 487 (1916) 4. E. Leifson

TB029

pET-5a rbsBgl II Xba I T7 promoter primer #69348-3 T7 promoter pBR322 EcoR I clockwise primer ori (2308) A p (3 06 9- 39 26 ) BamH I(4) Nhe I(37) Nde I(44) Xba

XP725 Antibody Number-Lot Number 071M4826

071M4826 A B C D a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5

FETAL HEMOGLOBIN

demonstration of fetal eryth ro cytes in the presence of adult blood cells. Am J Clin Pathol 40:487, 1963 8. Barr JK, Shafer JA: Preparation and storage of control slides for fetal hemoglobin determination

Product Information Sheet - S0501

Data Sheet 2. Rucki, R., Anal. Profiles of Drug Subs., K. Florey, ed. Academic Press, NY, 6, 487, 1977. 3. Frank, M.J., et al., J. Pharm. Sci., 65, 44, 1976. 4. Bult, A., et al., Anal. Profiles of Drug

Anti-NeuN, clone A60 - Data Sheet

al., Nature Medicine (2005) 11:538-544. 67) Peretto, P., et al., J. Comparative Neurology (2005) 487:407-427. 68) Scheffler, B., et al., PNAS (2005) 102:9353-9358. 69) Yang, P., et al., J. Comparative

Bioprocessing Technology Trends of RNA-Based Therapeutics and Vaccines

427 1104 15631488 976 295 1952 377 660 733 2009 8490 20152014 487 917 Monoclonal antibody Bioengineered vaccine Cell therapy DNA & RNA therapeutics Gene

Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy

al., Genetica, 117, 179-190 (2003). 26. Kraus, W.L. and Wong, J., Eur. J. Biochem., 269, 2275-2283 (2002). 27. Grozinger, C.M. and Schreiber, S.L., Chem. Biol., 9, 3-16 (2002). 28. Marmorstein, R., Biochem

Research Article: MCP-1, KC-like and IL-8 as critical mediators of

diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut. 2012 61(3):416–26. https://doi.org/10.1136/gutjnl-2011-300304 PMID: 21813474 Cytokines MCP-1, KC-like and IL-8

Solutions for Mass Spectrometry

Sample Spike 1 g of porcine kidney with 2 mL of stock solution (1 Metamitron 159 mg/L, 2 Carbetamid 487 mg/L, 3 Carbofuran 548 mg/L, 4 Isoproturon 159 mg/L, 5 Metazachlor 796 mg/L, 6 Metolachlor 395 mg/

XP725 Antibody List Lot 089K4791

R3777 4670 HNRNPM M NP_005959.2 y y y 486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d 487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d 488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2

XP725 Antibody List Lot 129K4831

R3777 4670 HNRNPM M NP_005959.2 y y y 486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d 487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d 488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2

XP725 Antibody List Lot 129K4830

R3777 4670 HNRNPM M NP_005959.2 y y y 486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d 487 NBS1 (Nibrin) N3037 4683 NBN P NP_002476.2 y n/d n/d 488 NBS1 (Nibrin) N3162 4683 NBN P NP_002476.2

3D BIOPRINTING: Printing a Brighter Future

D.-W. Nat. Biomed. Eng. 2019, 3, 509. (75) Tang, M.; Rich, J. N.; Chen, S. Adv. Mater. 2021, 33 (5), e2004776. doi. http://SigmaAldrich.com/matsci 26 Hybrid printing for Engineering

3D BIOPRINTING: Printing a Brighter Future

D.-W. Nat. Biomed. Eng. 2019, 3, 509. (75) Tang, M.; Rich, J. N.; Chen, S. Adv. Mater. 2021, 33 (5), e2004776. doi. http://SigmaAldrich.com/matsci 26 Hybrid printing for Engineering

Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation

Cetuximab® on a Chromolith® WP 300 RP-4, 100-4.6 mm 0 5 1 2 3 4 10 15 20 Time (min) 0 2 4 6 Time (min)

Halal Certificate

484. CIS-3-HEXENYL PROPIONATE W393304 C42599 HC-23SIDG90 485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-23SISF90 486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-23SIYP97 487. CIS-4-HEPTENAL

Halal Certificate

484. CIS-3-HEXENYL PROPIONATE W393304 C42599 HC-22SIQP12 485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-22SI5712 486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-22SI8Q19 487. CIS-4-HEPTENAL

List of Antibodies

y 484 Myosin VI M0691 M y y y 485 Myosin VI M5187 P n/d n/d y 486 NBS1 (Nibrin) N9287 M y n/d n/d 487 NBS1 (Nibrin) N3037 P y n/d n/d 488 NBS1 (Nibrin) N3162 P y n/d y 489 Nck-2 N2911 M y

XP725 Antibody List

VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y 486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d 487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN,Nbn NP_620228.1,NP_038780.3,NP_002476.2 P y n/d n/d 488

XP725 Worksheet for Lot Number 071M4826

482 3 3 1 2 E2F1 E8901 483 3 3 1 3 E2F2 E8776 484 3 3 1 4 E2F2 E8776 485 3 3 1 5 E2F3 E8651 486 3 3 1 6 E2F3 E8651 487 3 3 1 7 E2F4 E8526 488 3 3 1

XP725 Antibody List 013M4793